Market Access Today and Tomorrow

Understand key trends in Danish, Nordic and European market access

No available dates

On location

English

12,600 DKK ex VAT

(app. 1,694 EUR ex VAT)

50% DISCOUNT FOR PUBLIC INSTITUTIONS

SUMMARY

Departing from the current field of market access, this course you will introduce you to key developments within a European, Nordic, and local context that will determine what market access will look like in the future. We will especially focus on the new European Health Technology Assessment (HTA) process and what it will mean for national decision making. We will also deep dive into international payer collaborations and novel price agreements.

Participants will need some prior knowledge of market access. Workshops and group exercises are included in the course so that you may translate key insights from the lectures into a new understanding of the commercial, professional, and organizational challenges that you face now – and will face in the future.

KEYWORDS

  • EUnetHTA21
  • RWD/RWE
  • Innovative pricing agreements
  • Market and patient access
  • International payer collaborations


Hi! 

Do you need help choosing the right course? 

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com 

Stay tuned with Atrium's newsletter 


Save information for later
Read more

Course leader(s) & Lecturer(s)

  • Marlene Gyldmark
    Course leader
    Global Head Outcomes Research, Health Economics and Health Policy
    Roche Diabetes Care Diagnostics
  • Tove Holm-Larsen
    Lecturer
    CEO
    Pharmaevidence
  • Niels Christian Hirsch
    Lecturer
    Chefrådgiver
    DLI Market Intelligence ApS
  • Louise Broe
    Lecturer
    Sundhedspolitisk chefkonsulent
    Lif
  • Ansgar Hebborn
    Lecturer
    Head of Access Policy Affairs Europe
    F.HOFFMANN LA ROCHE LTD
  • Niklas Hedberg
    Lecturer
    Chief Pharmacist and Chair of the Executive Board - EUnetHTA
    TLV - Tandvårds- och läkemedelsförmånsverket
  • Dorthe Bartels
    Lecturer
    Senior rådgiver og forhandler
    Amgros I/S
  • Girisha Fernando
    Lecturer
    CEO
    Lyfegen HealthTech AG
  • Cecilie Astrup Frederiksen
    Lecturer
    Sundhedsøkonom
    Amgros I/S
  • Niels Christian Ganderup
    Lecturer
    Senior Investment Manager – HealthTech & Data
    Copenhagen Capacity
See all

IS THIS COURSE FOR YOU?

Are you involved in market access strategy either locally (Denmark) or in an European context? You may work in a Market Access role, Commercial role, Medical affairs or Public Affairs role.

WHAT YOU WILL LEARN 

  1. How European political and socio-economic developments impact national healthcare.
  2. How public health organizations, regulatory bodies, healthcare bodies, HTA bodies, and patient organizations work, think, and collaborate.
  3. What is going on at European level regarding the new HTA collaborations, what can we expect to see change?
  4. What will the implications be for the national reimbursement decisions following the implementation of the joint European HTA process in 2025?
  5. What are the opportunities and challenges of new innovative price negotiations?
  6. How Real World Data/Evidence will be part of authorities’ tool box for evaluating and prioritizing medicines

WHAT YOUR COMPANY WILL GET 

  1. An employee who understands how international and political trends affect national healthcare
  2. An employee who understands the challenges and opportunities of the new, joint HTA regulation in Europe and what that means for affiliate pharma organizations
  3. An employee who understands how future developments within innovative medicines, patient populations, Real World Evidence, health economics, and digitalized medicine treatments will set the demands on Market Access professionals’ and pharma organizations’ capabilities

Course information

Literature

Prior to the course you will get access to mandatory and/or optional readings via your personal Atrium log-in.

Examination

There is no examination for this course.

This course is a part of this programme

Pharma Consultant Diploma

Design a medical training programme that fits your professional interests. Relevant if you work with or advice on drugs, maybe as a professional in sales and marketing, market access or public affairs in the pharma industry

Read more
Diploma in Market Access

Our Diploma in Market Access provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses

Read more

Course leader(s)

Marlene Gyldmark
Global Head Outcomes Research, Health Economics and Health Policy
Roche Diabetes Care Diagnostics

Lecturer(s)

Marlene Gyldmark
Global Head Outcomes Research, Health Economics and Health Policy
Roche Diabetes Care Diagnostics
Tove Holm-Larsen
CEO
Pharmaevidence
Niels Christian Hirsch
Chefrådgiver
DLI Market Intelligence ApS
Louise Broe
Sundhedspolitisk chefkonsulent
Lif
Ansgar Hebborn
Head of Access Policy Affairs Europe
F.HOFFMANN LA ROCHE LTD
Niklas Hedberg
Chief Pharmacist and Chair of the Executive Board - EUnetHTA
TLV - Tandvårds- och läkemedelsförmånsverket
Dorthe Bartels
Senior rådgiver og forhandler
Amgros I/S
Girisha Fernando
CEO
Lyfegen HealthTech AG
Cecilie Astrup Frederiksen
Sundhedsøkonom
Amgros I/S
Niels Christian Ganderup
Senior Investment Manager – HealthTech & Data
Copenhagen Capacity

You may also be interested in these courses

WANT TO KNOW MORE or need help?

Contact Client Manager Ida Salicath at +45 39 15 09 46

Send me a message